Literature DB >> 10913185

RNA-Dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases.

L E Modahl1, T B Macnaughton, N Zhu, D L Johnson, M M Lai.   

Abstract

Cellular DNA-dependent RNA polymerase II (pol II) has been postulated to carry out RNA-dependent RNA replication and transcription of hepatitis delta virus (HDV) RNA, generating a full-length (1.7-kb) RNA genome and a subgenomic-length (0.8-kb) mRNA. However, the supporting evidence for this hypothesis was ambiguous because the previous experiments relied on DNA-templated transcription to initiate HDV RNA synthesis. Furthermore, there is no evidence that the same cellular enzyme is involved in the synthesis of both RNA species. In this study, we used a novel HDV RNA-based transfection approach, devoid of any artificial HDV cDNA intermediates, to determine the enzymatic and metabolic requirements for the synthesis of these two RNA species. We showed that HDV subgenomic mRNA transcription was inhibited by a low concentration of alpha-amanitin (<3 microgram/ml) and could be partially restored by an alpha-amanitin-resistant mutant pol II; however, surprisingly, the synthesis of the full-length (1.7-kb) antigenomic RNA was not affected by alpha-amanitin to a concentration higher than 25 microgram/ml. By several other criteria, such as the differing requirement for the de novo-synthesized hepatitis delta antigen and temperature dependence, we further showed that the metabolic requirements of subgenomic HDV mRNA synthesis are different from those for the synthesis of genomic-length HDV RNA and cellular pol II transcripts. The synthesis of the two HDV RNA species could also be uncoupled under several different conditions. These findings provide strong evidence that pol II, or proteins derived from pol II transcripts, is involved in mRNA transcription from the HDV RNA template. In contrast, the synthesis of the 1.7-kb HDV antigenomic RNA appears not to be dependent on pol II. These results reveal that there are distinct molecular mechanisms for the synthesis of these two RNA species.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10913185      PMCID: PMC86079          DOI: 10.1128/MCB.20.16.6030-6039.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  40 in total

1.  trans-dominant inhibition of human hepatitis delta virus genome replication.

Authors:  J S Glenn; J M White
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

2.  Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen.

Authors:  M Y Kuo; M Chao; J Taylor
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

3.  Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication.

Authors:  M Chao; S Y Hsieh; J Taylor
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

Review 4.  The molecular biology of hepatitis delta virus.

Authors:  M M Lai
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

5.  A pseudoknot ribozyme structure is active in vivo and required for hepatitis delta virus RNA replication.

Authors:  K S Jeng; A Daniel; M M Lai
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

6.  Promoter-selective transcriptional defect in cell cycle mutant ts13 rescued by hTAFII250.

Authors:  E H Wang; R Tjian
Journal:  Science       Date:  1994-02-11       Impact factor: 47.728

7.  The RNAs of hepatitis delta virus are copied by RNA polymerase II in nuclear homogenates.

Authors:  T B Fu; J Taylor
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

8.  Polyadenylation of the mRNA of hepatitis delta virus is dependent on the structure of the nascent RNA and regulated by the small or large delta antigen.

Authors:  S Y Hsieh; P Y Yang; J T Ou; C M Chu; Y F Liaw
Journal:  Nucleic Acids Res       Date:  1994-02-11       Impact factor: 16.971

9.  RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase.

Authors:  A G Polson; B L Bass; J L Casey
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

10.  Hepatitis D virus RNA editing: specific modification of adenosine in the antigenomic RNA.

Authors:  J L Casey; J L Gerin
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

View more
  45 in total

1.  Genomic but not antigenomic hepatitis delta virus RNA is preferentially exported from the nucleus immediately after synthesis and processing.

Authors:  Thomas B Macnaughton; Michael M C Lai
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  A single-stranded promoter for RNA polymerase III.

Authors:  Oliver Schroder; E Peter Geiduschek; George A Kassavetis
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

3.  Nonreplicative homologous RNA recombination: promiscuous joining of RNA pieces?

Authors:  Anatoly P Gmyl; Sergey A Korshenko; Evegny V Belousov; Elena V Khitrina; Vadim I Agol
Journal:  RNA       Date:  2003-10       Impact factor: 4.942

4.  Hepatitis delta virus antigen is methylated at arginine residues, and methylation regulates subcellular localization and RNA replication.

Authors:  Yi-Jia Li; Michael R Stallcup; Michael M C Lai
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

5.  Reconstitution in cultured cells of replicating HDV RNA from pairs of less than full-length RNAs.

Authors:  Severin O Gudima; Jinhong Chang; John M Taylor
Journal:  RNA       Date:  2004-12-01       Impact factor: 4.942

Review 6.  RNA replication without RNA-dependent RNA polymerase: surprises from hepatitis delta virus.

Authors:  Michael M C Lai
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  RNA-templated replication of hepatitis delta virus: genomic and antigenomic RNAs associate with different nuclear bodies.

Authors:  Yi-Jia Li; Thomas Macnaughton; Lu Gao; Michael M C Lai
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

8.  Determination of the multimerization state of the hepatitis delta virus antigens in vivo.

Authors:  Cromwell T Cornillez-Ty; David W Lazinski
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Combined proteomic-RNAi screen for host factors involved in human hepatitis delta virus replication.

Authors:  Dan Cao; Dirk Haussecker; Yong Huang; Mark A Kay
Journal:  RNA       Date:  2009-09-23       Impact factor: 4.942

10.  Large hepatitis delta antigen is not a suppressor of hepatitis delta virus RNA synthesis once RNA replication is established.

Authors:  Thomas B Macnaughton; Michael M C Lai
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.